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Abstract
There is persuasive evidence, including the present report by
Dubin and colleagues, of a dissociation between increases in
arterial pressure produced by vasopressor agents and improve-
ment in microvascular perfusion and delivery of vital substrates.
Especially in settings of septic shock, the current routine
administration of adrenergic vasopressor therapy therefore may fail
to reverse the primary defect.
The largely universal treatment of hypotension associated
with cardiogenic, distributive (septic) and obstructive shock
states with adrenergic vasopressor agents in the past century
is based on the goal of restoring blood pressure to more
normal levels. However, the evidence that such treatment
improves outcomes is assumed, and, as yet, is not backed by
the security of proven value based on controlled clinical trials.
The current focus of treatment of shock states, including
septic shock, has been almost entirely on the macro-
circulation, including heart rate and rhythm, arterial pressure,
cardiac filling pressures and cardiac output, arterial and
mixed venous oxygen saturation, and calculated oxygen
delivery and utilization. These hemodynamic variables are
used to guide fluid repletion and vasopressor-inotropic
interventions in an effort to optimize their values.
With the recent availability of non-invasive techniques for
visualization of the microcirculation in both clinical and experi-
mental settings, there is now persuasive evidence of a disso-
ciation between cardiac output and aortic/arterial pressures
and the extent to which flow is delivered to the capillary
exchange vessels, specifically in settings of septic shock
[1,2]. Despite achieving numerically more normal systemic
flow and oxygen delivery, the defect at the microcirculation
level is such that capillary blood flow fails to be sustained.
We suspect, but have not proven, that there is shunting
between pre-capillary arterioles and post-capillary venules,
accounting for the prominent increases in mixed venous
oxygen saturation that are typical of the initial stages of septic
shock. If vasopressor drugs such as norepinephrine are
administered to achieve more normal levels of arterial
pressure, they may not favorably affect capillary perfusion
and, thereby, mitigate the failure of oxygen and other sub-
strate delivery and exchange. In the present issue of Critical
Care, Dubin and colleagues [1] measured effects of
norepinephrine on the microcirculation in the sublingual
mucosa of patients with hypotension in settings of sepsis.
The authors confirmed the previously reported micro-
circulatory abnormalities in their patients with septic shock
[1]. When norepinephrine was administered so as to increase
mean arterial pressure in increments from 65 to 85 mmHg,
there was no improvement in capillary perfusion in the
sublingual mucosa and sometimes even decreases.
These observations are admittedly preliminary and were
derived from a relatively small and diverse population of
patients with microcirculatory measurements limited to a
single sublingual site, although there is evidence that such
decreases in sublingual mucosal capillary flows are reflective
of decreases in organ perfusion [3]. These findings may also
be viewed in the context of a recent report from our group in
which adrenergic drugs had adverse effects on the micro-
circulation. In settings of cardiopulmonary resuscitation, for
instance, the administration of epinephrine decreased micro-
circulatory flow to the cerebral cortex and increased the
severity of cortical ischemia, even though arterial pressure
and even large vessel arterial flow were increased [4].
We are reminded of yesteryear, when purgatives and blood
letting were the established therapies. In the 18th and even
the 19th centuries, these were intended to rid the patient’s
body of the injurious invaders in the blood and the gut
responsible for disease. These hastened the demise of even
our historically most notable leader, first President of the
United States, George Washington, who was purged and
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from whom more than one half of his estimated blood volume
was removed for treatment of what was more likely strepto-
coccal pharyngo-epiglotitis [5]. Current ethics constraints are
such that a challenge to established practices, including the
use of adrenergic vasopressor agents in life threatening
settings, including cardiopulmonary resuscitation, are not
eligible for objective review, including placebo controls.
Accordingly, the objective evidence contributed by Dubin and
associates that points to a lack of benefit from vasopressor
agents in the management of hypotension and raises the
potential for adverse effects may favor optimism that the need
for objectively controlled, randomized re-examination of the
roles of these so widely used vasopressor and inotropic
interventions will be ethically sanctioned.
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